Trials / Completed
CompletedNCT02872818
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Kayseri Education and Research Hospital · Other Government
- Sex
- Female
- Age
- 8 Weeks – 10 Weeks
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine apoptotic signaling pathways such as Survivin, Bcl-2, Bax, c-Myc and caspase-9 expression levels in rats model with iatrogenic endometrial hyperplasia after metformin and medroxyprogesterone acetate administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 17β estradiol hemihydrate | 4mg/kg/day for 20 days |
| DRUG | Metformin | 50 mg/kg/day last 10 days |
| DRUG | medroxyprogesterone acetate | 1mg/kg/day last 10 days |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2016-08-19
- Last updated
- 2016-08-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02872818. Inclusion in this directory is not an endorsement.